“I am an
old-fashioned physician, and if I know of people who are at an 86% risk
of cancer I just want to go with them and prevent this from happening,”
Stefansson says. “But there are those who want to approach them
indirectly. That is the debate for society.”
The CEO of an
Icelandic gene-hunting company says he is able to identify everyone from
that country who has a deadly cancer risk, but has been unable to warn
people of the danger because of ethics rules governing DNA research.
found they achieved optimal detection of tumours by analysing a series
of parameters taken by magnetic resonance imaging, including measures of
blood vessel growth and of choline, polyamines and creatine.
oncologist, David Hyman at Memorial Sloan Kettering, enrolled Anselmo
into a new kind of drug trial. Called a basket trial, the study is
designed to include people whose tumors have the same kind of genetic
fingerprint regardless of where in the body the tumors are found.
industry leaders Novartis, Juno Therapeutics and Kite Pharma, Cellectis'
approach to CAR-T uses off-the-shelf T cells harvested from third-party
patients, a method the company believes will lead to best-in-class
In a new study
involving mice, aerobic exercise slowed the growth of breast cancer
tumors and made the cancer more sensitive to chemotherapy. The results
raise the possibility that exercise may change the biology of some
malignant tumors, potentially making them easier to treat.
found Britons were much more likely to be embarrassed about coming
forward or put off by fear they may be wasting the time of their doctor
than people from other countries. When it comes to cancer, the problems
may be more intractable than the headlines suggest.
Global Oncology, Inc. has launched a Global Cancer Project Map, a
first-of-its-kind resource that will connect cancer experts around the
world in an effort to advance cancer research and care in low-resource
Josephson decline treatment? "It would be at the point where it was
pretty hopeless," she says. "But I haven't gotten to that point yet at
all, not in my mind and not in reality. And I've discussed it with the
kids, and I said, 'Don't you dare pull the plug on me too fast.' "
As much as I
admire the grace and determination with which Stefanie LaRue has endured
over 9 years after her cancer diagnosis, as a cancer doctor it bothers
me profoundly that she has allowed herself to fall under the spell of
the “cannabis cures cancer” alternative medicine crowd.
My own work on
this issue demonstrated that the news media had an overwhelmingly
positive slant toward Ms. Jolie’s decision to get a double mastectomy.
But the stories almost always overlooked the relative rarity of her
situation. Important context was left out.